In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 15th, 2009 | 35 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.41 | 7.21 | -79.95 | 6 | 11 | 0 | 176 | 486.573 | 11 | ↓ |
Lo Low (pH 4.5-6) | -0.41 | 6.09 | -52.54 | 7 | 11 | 1 | 173 | 487.581 | 11 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ITA2B-1-E | Integrin Alpha-IIb (cluster #1 Of 1), Eukaryotic | Eukaryotes | 271 | 0.26 | Binding ≤ 10μM |
ITB3-1-E | Integrin Beta-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 271 | 0.26 | Binding ≤ 10μM |
ITA2B-1-E | Integrin Alpha-IIb (cluster #1 Of 2), Eukaryotic | Eukaryotes | 720 | 0.25 | Functional ≤ 10μM |
ITB3-1-E | Integrin Beta-3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 720 | 0.25 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ITA2B_HUMAN | P08514 | Integrin Alpha-IIb, Human | 271 | 0.26 | Binding ≤ 1μM |
ITB3_HUMAN | P05106 | Integrin Beta-3, Human | 271 | 0.26 | Binding ≤ 1μM |
ITA2B_HUMAN | P08514 | Integrin Alpha-IIb, Human | 271 | 0.26 | Binding ≤ 10μM |
ITB3_HUMAN | P05106 | Integrin Beta-3, Human | 271 | 0.26 | Binding ≤ 10μM |
ITA2B_HUMAN | P08514 | Integrin Alpha-IIb, Human | 720 | 0.25 | Functional ≤ 10μM |
ITB3_HUMAN | P05106 | Integrin Beta-3, Human | 720 | 0.25 | Functional ≤ 10μM |
Description | Species |
---|---|
ECM proteoglycans | |
Elastic fibre formation | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Molecules associated with elastic fibres | |
p130Cas linkage to MAPK signaling for integrins | |
PECAM1 interactions | |
Platelet degranulation | |
Signal transduction by L1 | |
Syndecan interactions | |
VEGFA-VEGFR2 Pathway |